Post-IPO Equity Pharmaceutical Companies

A health sciences company that develops innovative options for preventive and curative therapies .

CERo Therapeutics, Inc. is a new cellular immunotherapy company.

Prelude Therapeutics designs and develops small molecule therapies targeting key drivers of cancer cell growth and resistance.

Hepion Pharmaceuticals is a clinical stage biopharmaceutical company.

Spruce Biosciences is a biopharmaceutical company developing therapies for rare diseases that target the endocrine system.

Acurx Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing new antibiotics for difficult to treat infections.

Trevi Therapeutics is a clinical-stage biopharmaceutical company that develops drugs for treating uremic pruritus.

Allogene Therapeutics is a biotechnology company catalyzing cancer treatment through the development of CAR T therapy.

NewcelX is a clinical-stage drug development company focusing on neurobehavioral and neurocognitive disorders and their pharmacognosia.

Korro Bio provides an efficient and selective method for RNA editing, leveraging natural processes common to all multi-cellular organisms.

AN2 Therapeutics focuses on modern biomedical and drug development expertise to provide transformational medicines.

Blueberries Medical is a producer of medicinal cannabis products.

Newbury Pharmaceuticals is building a pipeline of proprietary and licensed products to become a leading generic pharma company.

Mountain Valley MD Holdings is in the final stages of proving up a low-cost, low-risk exploration project.

Cube Labs is the first systematic venture builder in the healthcare technology space in Italy.

Calithera Biosciences is a pharmaceutical company developing novel small molecule therapeutics for the treatment of cancer.

Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.

Artelo Biosciences aims to accelerate the development and commercialization of endocannabinoid system modulating therapeutics.

Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.

Stoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for treatment.

Acticor Biotech is a biopharmaceutical company developing an innovative drug for the treatment in the acute phase of ischemic stroke.

ASLAN Pharmaceuticals is an oncology-focused biotechnology company developing a portfolio of immuno-oncology agents and targeted therapies.

Lancaster Resources is a dynamic exploration company dedicated to the emerging energy sector transition opportunity.

Autolus is a biopharmaceutical company focused on T-cell programming and manufacturing technology.

Mustang Bio is a clinical-stage biopharmaceutical company .